Physician

Sushil Ghimire, M.D.

According to 2025 Medicare claims, Sushil Ghimire, M.D. (NPI: 1912314840) practices hematology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CMC DEPARTMENT OF MEDICINE GROUP PA (NPI: 1588796882; TIN: 223266219) and primary practice location at 08043-4637.

Ghimire's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 604 HCPCS/CPT codes, and received $40,882 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,218 prescription claims across 154 beneficiaries totaling $7,222,271 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $721 to $7,222,271. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$22K$43K2017 Medicare payment: $23,461 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $24,773 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $11,878 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $37,733 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $43,215 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $40,882 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017169348$23,461
2018168380$24,773
2019N/RN/RN/R
2020N/RN/RN/R
202170126$11,878
2022195475$37,733
2023217533$43,215
2024246604$40,882

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6M$7.2M2015 Drug cost: $721 (USD; Tot_Drug_Cst)2016 Drug cost: $3,128 (USD; Tot_Drug_Cst)2017 Drug cost: $15,953 (USD; Tot_Drug_Cst)2018 Drug cost: $38,692 (USD; Tot_Drug_Cst)2021 Drug cost: $243,527 (USD; Tot_Drug_Cst)2022 Drug cost: $1,893,083 (USD; Tot_Drug_Cst)2023 Drug cost: $5,630,064 (USD; Tot_Drug_Cst)2024 Drug cost: $7,222,271 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151938$721
20162057$3,128
201766155$15,953
201854213$38,692
2019N/RN/RN/R
2020N/RN/RN/R
202153158$243,527
202299631$1,893,083
20231421,103$5,630,064
20241541,218$7,222,271

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1919$151
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more172343$73
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2647$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2829$45
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6182$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide792,142$1,441,245
CalquenceAcalabrutinib Maleate942,820$1,246,786
PomalystPomalidomide521,456$1,140,268
ImbruvicaIbrutinib732,110$1,064,440
JakafiRuxolitinib Phosphate411,230$686,879

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$17Alnylam Pharmaceuticals Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sushil Ghimire, M.D.?

Tedicare shows public-source Medicare data for Sushil Ghimire, M.D. (NPI 1912314840), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sushil Ghimire, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sushil Ghimire, M.D.?

Sushil Ghimire, M.D. is linked to CMC DEPARTMENT OF MEDICINE GROUP PA (billing NPI 1588796882) in the available physician profile data.

Does Sushil Ghimire, M.D. have Open Payments data?

Sushil Ghimire, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.